Skip to content

A case-control and mechanistic study of high-precision transcranial direct current stimulation (HD-tDCS) for generalized anxiety disorder

A case-control and mechanistic study of high-precision transcranial direct current stimulation (HD-tDCS) for generalized anxiety disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107964
Enrollment
Unknown
Registered
2025-08-21
Start date
2025-08-21
Completion date
Unknown
Last updated
2025-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized anxiety disorder

Interventions

Healthy Control Group:None
HD-tDCS Sham Group:High-definition direct current stimulation(pseudo-stimulation mode)
HD-tDCS Active Stimulation Group:High-definition direct current stimulation

Sponsors

Affiliated Kangning Hospital of Ningbo University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Healthy control group : (1) Normal mental status examination; (2) Hamilton Anxiety Rating Scale (HAMA) score <=7; (3) Aged 18-65 years, matched with the anxiety disorder group in terms of age, gender, marital status, years of education, and social functioning variables; (4) Willing to participate in this study and having signed the informed consent form. 2.GAD patients: (1) Meeting the diagnostic criteria for generalized anxiety disorder (GAD) according to the International Classification of Diseases, 10th Revision (ICD-10); (2) Aged 18–65 years; (3) Hamilton Anxiety Rating Scale (HAMA) score =15; (4) Right-handed; (5) Willing to participate and having provided written informed consent.

Exclusion criteria

Exclusion criteria: 1. Healthy control group: (1) severe physical diseases; (2) mental retardation or mental retardation (IQ<90); (3) Pregnant women; (4) Previous history of mental disorders or family history of mental disorders; (5) History of psychoactive substance abuse. 2. GAD patients: (1) Patients with severe physical diseases, infectious diseases and immune system diseases; (2) Patients with severe neurological diseases, mental retardation or brain organic diseases; (3) Pregnant or lactating women; (4) Those who have received electroconvulsive therapy in the past 3 months; (5) History of seizures; (6) Metal implants in the body.

Design outcomes

Primary

MeasureTime frame
Cognitive Function Level;Functional Near-infrared Spectroscopy,fNIRS;Anxiety Symptom Severity;

Secondary

MeasureTime frame
Depressive Symptom Severity;

Countries

China

Contacts

Public ContactYuanyuan Zhang

Affiliated Kangning Hospital of Ningbo University

lanxin2929@163.com+86 574 2630 2525

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026